Capitol Clarity / Lobbyists / M / Nicolas Magallanes

Nicolas Magallanes: federal lobbyist

Nicolas Magallanes is named as a lobbyist on federal disclosure filings for 27 clients through Todd Strategy Group and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Pharmacy and Trade (domestic/foreign).

27Clients on filings
2Registrants
14Issue categories
2Years with reports

Former government positions listed

Filers must list covered executive or legislative branch positions held. As filed:

Clients and registrants

ClientRegistrantLatestIssues
MCKESSON CORPORATIONTODD STRATEGY GROUPQ3 2026Medicare/Medicaid
U.S. CHAMBER OF COMMERCE GLOBAL INNOVATION POLICY CENTERTODD STRATEGY GROUPQ3 2026Copyright/Patent/Trademark
MENARINI GROUPTODD STRATEGY GROUPQ3 2026Medicare/Medicaid
ELI LILLY AND COMPANYTODD STRATEGY GROUPQ3 2026Medicare/Medicaid, Health Issues, Pharmacy
ASTELLAS PHARMA US, INC.TODD STRATEGY GROUPQ3 2026Pharmacy, Health Issues, Copyright/Patent/Trademark
FOX CORPORATIONTODD STRATEGY GROUPQ3 2026Communications/Broadcasting/Radio/TV
NOVO NORDISK INC.TODD STRATEGY GROUPQ3 2026Pharmacy, Health Issues
COMPASS PATHWAYS INC.TODD STRATEGY GROUPQ3 2026Health Issues
AMERICAN SOCIETY OF NEPHROLOGYTODD STRATEGY GROUPQ3 2026Health Issues
ASTRAZENECA PHARMACEUTICALS LPTODD STRATEGY GROUPQ3 2026Medicare/Medicaid, Health Issues, Tariff (miscellaneous tariff bills)
AMGEN INC.TODD STRATEGY GROUPQ3 2026Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code
SUNBOUND HOMESTODD STRATEGY GROUPQ3 2026Medicare/Medicaid
PFIZER INC.TODD STRATEGY GROUPQ3 2026Trade (domestic/foreign), Medicare/Medicaid, Pharmacy
GILEAD SCIENCES, INC.TODD STRATEGY GROUPQ3 2026Health Issues
BRISTOL-MYERS SQUIBB COMPANYTODD STRATEGY GROUPQ3 2026Medicare/Medicaid, Health Issues, Pharmacy
BIOGEN, INC.TODD STRATEGY GROUPQ3 2026Medicare/Medicaid, Health Issues, Pharmacy
THE COALITION FOR 21ST CENTURY MEDICINETODD STRATEGY GROUPQ3 2026Medicare/Medicaid
TAKEDA PHARMACEUTICALS AMERICA, INC.TODD STRATEGY GROUPQ3 2026Trade (domestic/foreign), Medicare/Medicaid, Health Issues
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICATODD STRATEGY GROUPQ3 2026Trade (domestic/foreign), Budget/Appropriations, Medicare/Medicaid
NOVARTIS, INC.TODD STRATEGY GROUPQ3 2026Trade (domestic/foreign), Medicare/Medicaid, Health Issues
NCTA - THE INTERNET & TELEVISION ASSOCIATIONTODD STRATEGY GROUPQ3 2026Telecommunications
JOHNSON & JOHNSON SERVICES, INC.TODD STRATEGY GROUPQ3 2026Veterans, Health Issues
BAYER CORPORATIONTODD STRATEGY GROUPQ3 2026Trade (domestic/foreign), Taxation/Internal Revenue Code, Medicare/Medicaid
PMI US CORPORATE SERVICES INC.TODD STRATEGY GROUPQ3 2026Tobacco, Government Issues, Budget/Appropriations
GENENTECH, INC.TODD STRATEGY GROUPQ3 2026Budget/Appropriations, Medicare/Medicaid, Health Issues
ALNYLAM PHARMACEUTICALS, INC.TODD STRATEGY GROUPQ3 2026Trade (domestic/foreign), Medicare/Medicaid, Pharmacy
ILLUMINA, INC.ILLUMINA, INC.Q3 2025Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code

Activity by year

YearClientsRegistrants
2026261
202542

Contributions reported on Form LD-203

YearItemsTotal
20266$16K

Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Nicolas Magallanes. See the Capitol Clarity rankings and method.